Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-08-03
2010-10-26
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07820719
ABSTRACT:
A drug composition containing as a drug substance a polymeric guanidine derivative based on a diamine containing oxyalkylene chains between two amino groups, with the guanidine derivative representing a product of polycondensation between a guanidine acid addition salt and a diamine containing polyalkylene chains between two amino groups, as well as the pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 2336605 (1943-12-01), Ernsberger et al.
patent: 1990 0121254 (1991-08-01), None
patent: 1990 0121255 (1991-08-01), None
patent: 1816769 (1993-05-01), None
patent: WO 01/85676 (2001-11-01), None
Gurjal et al., Emerging Drugs (2000), 5(3):273-285.
Astra Zeneca (2004) 1 page.
www.tribunes.com-the cancer Journal vol. 8 (3) 1995 1-4.
Barry J1404 Apr. 2002 1 pg Prevention of Crown Galls (plant cancer) in plant) is of interest.
Baker & Botts L.L.P.
Gembeh Shirley V
Geopharma Produktions GmbH
Hartley Michael G
LandOfFree
Cytostatic drug composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytostatic drug composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytostatic drug composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153878